Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Thomas Ciulla, MD
Clearside Biomedical, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Miami, Florida, United States
- Facility name not stated
Atlanta, Georgia, United States
- Facility name not stated
Chicago, Illinois, United States
- Facility name not stated
Boston, Massachusetts, United States
- Facility name not stated
Waltham, Massachusetts, United States
- Facility name not stated
Omaha, Nebraska, United States
- Facility name not stated
New York, New York, United States
- Facility name not stated
Winston-Salem, North Carolina, United States
- Facility name not stated
Fargo, North Dakota, United States
- Facility name not stated
Cleveland, Ohio, United States
- Facility name not stated
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2014
- Primary completion
- 31 Dec 2015
- Completion
- 31 Jan 2016
- Last update posted
- 8 Feb 2021
- Registered enrollment
- 22
- Registry id
- NCT02255032
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.